Publications & Resources

This report provides findings from an analysis of Medicare Benefits Schedule (MBS) data for the months January 2020 to June 2020 to understand where changes in the number of cancer-related services have occurred, and the types of services affected during the COVID-19 pandemic. These analyses focus on changes in cancer-related diagnostic and treatment procedures for lung and prostate cancers.

This information is for women who have been treated for early breast cancer or ductal carcinoma in situ (DCIS) and their carers. It provides information about shared follow-up and survivorship care, including the benefits of shared care and who is involved.

Cancer Australia's Annual Report for the 2019-2020 reporting period

This document contains the 200 recommendations and practice points that comprise the Guidance for the management of early breast cancer. The Guidance has been developed as an essential resource for health professionals involved in the management of women and men with breast cancer. It updates and replaces in full or in part Cancer Australia’s 2001 Clinical Practice Gguidelines for the management of breast cancer in women and various subsequent topic-specific updates. This Guidance has been developed to meet the need for comprehensive, up-to-date, evidence-based guidance that encompasses management of early breast cancer from the point of diagnosis. The Guidance is also presented in a user-friendly, accessible format on a Cancer Australia featured site at www.guidancebreastcancer.gov.au.

This reportdescribes the approach taken to develop the Guidance for the Managment of the early breast cancer.

The COVID-19 pandemic has prompted unprecedented changes in cancer care across the cancer care pathway and in many parts of the oncology sector. This report describes elements of cancer care which have changed during the COVID-19 pandemic; the impacts of these changes; and targeted strategies (at the system-level, service-level, practitioner-level, and patient-level) to retain, enhance, and embed high-value changes into practice. These targeted strategies are provided to prompt considerations and future approaches to support high-value cancer care in the recovery phases of the COVID-19 pandemic.

This report provides findings from an analysis of Medicare Benefits Schedule (MBS) for the months January 2020 to June 2020 to understand where changes in the number of cancer-related services have occurred, and the types of services affected during the COVID-19 pandemic. The current analyses focus on changes in cancer-related diagnostic and treatment procedures for skin, breast and colorectal cancers, and selected professional attendances using MBS item numbers including the new telehealth services made available during the pandemic.

The summary of evidence outlines the evidence base that supports and informs Cancer Australia’s Shared follow-up and survivorship care model for women with low-risk endometrial cancer. The purpose is to provide the context, evidence base and, where applicable, the consensus base for Cancer Australia’s shared follow-up care model and resources. The primary audience is health professionals and other stakeholders involved in the uptake and implementation of a shared model of follow-up care for women with low-risk endometrial cancer.

The guide assists health professionals in the delivery of culturally safe and responsive cancer care.

This conceptual framework uses published data and guidance to explore system-wide approaches to cancer management during the COVID-19 pandemic. These approaches are in the context of various epidemiological scenarios of COVID-19 cases, across the cancer pathway from prevention and early detection through to survivorship and end-of-life care, and have been developed in accordance with the principles of the Optimal Care Pathways for people with cancer. This report has been superseded by A conceptual framework for cancer care during a pandemic incorporating evidence from the COVID-19 pandemic.